Navigation Links
FDA Approves New Dosing for FASLODEX® (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
Date:9/10/2010

ASLODEX has not been evaluated in patients with severe hepatic impairment (Child-Pugh Class C).

Fetal harm can occur when administered to a pregnant woman. Women should be advised of the potential hazard to the fetus and to avoid becoming pregnant while receiving FASLODEX.

The most common, clinically significant adverse reactions occurring in ≥5% of patients receiving FASLODEX were: injection site pain, nausea, bone pain, arthralgia, headache, back pain, fatigue, pain in extremity, hot flash, vomiting, anorexia, asthenia, musculoskeletal pain, cough, dyspnea, and constipation.

Increased hepatic enzymes (ALT, AST, ALP) occurred in >15% of FASLODEX users and were non dose-dependent.

Approved Use For FASLODEX

FASLODEX is indicated for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

Please see full Prescribing Information. If you have any questions concerning FASLODEX, please contact AstraZeneca Information Center at 1-800-236-9933, open Monday to Friday from 8 AM to 6 PM, excluding holidays.

About CONFIRM

CONFIRM (COmparisoN of FASLODEX In Recurrent or Metastatic breast cancer) was a Phase III, randomized, double-blind, parallel-group, multi-center trial comparing fulvestrant 500 mg (n=362) and 250 mg (n=374) in postmenopausal women with estrogen receptor-positive advanced breast cancer, who progressed or recurred following one prior endocrine therapy (antiestrogen or aromatase inhibitor). Eligible patients were randomized 1:1 to fulvestrant 500mg or 250mg, and assessed for tumor progression every 12 weeks. The primary objective was to compare the efficacy of both treatment groups in terms of progression free survival. Secondary objectives included: objective response rate (ORR), clinical benefit rate (CBR), duration of clinical ben
'/>"/>

SOURCE AstraZeneca
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Pediatric Use of Chemical Poisoning Treatment
2. FDA Approves Merz Pharmaceuticals Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
3. FDA Approves Vaccines for the 2010-2011 Influenza Season
4. FDA Approves Strativa Pharmaceuticals Zuplenz® (ondansetron) Oral Soluble Film
5. FDA Approves Sagent Pharmaceuticals Heparin Sodium Injection, USP
6. U.S. FDA Approves Improved Performance of Riverain Medicals OnGuard Chest X-ray Computer-Aided Detection Technology
7. FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women
8. FDA Approves New Treatment for Late-Onset Pompe Disease
9. FDA Approves Cefepime for Use In B. Brauns DUPLEX(R) System
10. U.S. FDA Approves Natazia(TM), a New Oral Contraceptive for the Prevention of Pregnancy
11. FDA Approves New Combination Product Oral Contraceptive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014 Endo International plc (NASDAQ: ... revenues of $719 million, an increase of 1 percent ... Endo reported net income of $21 million in the ... million in the second quarter of 2013.  As detailed ... for the three months ended June 30, 2014 increased by ...
(Date:7/31/2014)... , 2014 Second Quarter Total Revenue $2.0 billion; an ... growth was 4% for same store sales and 8% pro ... 12% , 2014 Second Quarter GAAP EPS $0.37; Cash ... Quarter GAAP Operating Cash Flow $376 million; Adjusted Operating Cash ... Quarter , Launched 17 new products in the U.S. year-to-date ...
(Date:7/31/2014)... -- Today,s Consumer Reports story on prescription and non-prescription ... consumers of the importance of taking medicines safely ... the Acetaminophen Awareness Coalition,s (AAC) Know ... in 2010, the Coalition is a group of ... to educating consumers on safe acetaminophen use to ...
Breaking Medicine Technology:Endo Reports Second Quarter Financial Results 2Endo Reports Second Quarter Financial Results 3Endo Reports Second Quarter Financial Results 4Endo Reports Second Quarter Financial Results 5Endo Reports Second Quarter Financial Results 6Endo Reports Second Quarter Financial Results 7Endo Reports Second Quarter Financial Results 8Endo Reports Second Quarter Financial Results 9Endo Reports Second Quarter Financial Results 10Endo Reports Second Quarter Financial Results 11Endo Reports Second Quarter Financial Results 12Endo Reports Second Quarter Financial Results 13Endo Reports Second Quarter Financial Results 14Endo Reports Second Quarter Financial Results 15Endo Reports Second Quarter Financial Results 16Endo Reports Second Quarter Financial Results 17Endo Reports Second Quarter Financial Results 18Endo Reports Second Quarter Financial Results 19Endo Reports Second Quarter Financial Results 20Endo Reports Second Quarter Financial Results 21Endo Reports Second Quarter Financial Results 22Endo Reports Second Quarter Financial Results 23Endo Reports Second Quarter Financial Results 24Endo Reports Second Quarter Financial Results 25Endo Reports Second Quarter Financial Results 26Endo Reports Second Quarter Financial Results 27Endo Reports Second Quarter Financial Results 28Endo Reports Second Quarter Financial Results 29Endo Reports Second Quarter Financial Results 30Endo Reports Second Quarter Financial Results 31Endo Reports Second Quarter Financial Results 32Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 3Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 4Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 5
... 2011 Ventana Medical Systems, Inc . (Ventana), ... first-of-its-kind integration of the VIRTUOSO digital pathology software and ... integration to the anatomic pathology lab. The ... track the progress of a slide from preparation to ...
... 27, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: ... manufacturer and marketer of orthopedic implants in China, today announced ... Bank of America Merrill Lynch New China Conference to be ... JW Marriot Hotel in Beijing, China.  Management is scheduled to ...
Cached Medicine Technology:Ventana Medical Systems, Inc. Introduces Groundbreaking Laboratory Workflow Integration 2Ventana Medical Systems, Inc. Introduces Groundbreaking Laboratory Workflow Integration 3China Kanghui Holdings Announces Participation in Upcoming Investor Conferences 2
(Date:7/31/2014)... ProtonPACS, a division of Radsource, has ... Rural Health Association (NRHA), company officials announced today. The ... needs of rural health providers nationwide. , “We are ... said Dr. Mark Awh, President of Radsource. “While we ... we are also looking forward to learning from all ...
(Date:7/31/2014)... Boston, MA (PRWEB) July 31, 2014 Many ... fight for the weak, to correct injustices, and preserve the ... - action that can be lauded as crusading and exemplary ... the lawyer takes on corruption whose seed might be planted ... a fury and the ultimate punishment for an attorney - ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Computer Resources ... firm based in New York City, has been awarded ... the midtown Manhattan headquarters of a large global bank. ... investment banking. , Chico Ramnarayan, Chief Executive Officer of ... is an opportunity for us to further develop what ...
(Date:7/31/2014)... Loffler Companies, the leading business technology and ... Microsoft as a Microsoft Community Connections Partner of the ... 14, 2014. , The Microsoft U.S. SMB Champions ... cloud-based IT services and solutions to small and midsized ... SMB Champions Club member, Loffler has established a proven ...
(Date:7/31/2014)... 31, 2014 According to new ... Wheat, Mycoprotein), by Type (Tofu, Tofu-Based Product, Tempeh, ... - Global Trends & Forecasts to 2019", defines ... an analysis and forecasting of the market value ... The report also identifies the driving and restraining ...
Breaking Medicine News(10 mins):Health News:ProtonPACS Announces Pipeline Partnership with the National Rural Health Association. 2Health News:Supreme Court Press Petition of the Month for July 2014: Shutting Down Inconvenient Lawyers By Disbarment or Suspension 2Health News:Supreme Court Press Petition of the Month for July 2014: Shutting Down Inconvenient Lawyers By Disbarment or Suspension 3Health News:Global Bank Awards CRA with Network Infrastructure Contract 2Health News:Loffler Companies Named Microsoft Community Connections Partner of the Year Award Winner 2Health News:Loffler Companies Named Microsoft Community Connections Partner of the Year Award Winner 3Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 2Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 3
... by researchers at Wake Forest University Baptist Medical Center is ... weight loss in older adults leads to increased risk of ... intentionally exercised and/or modified their diets to lose weight were ... as their peers who did not work toward weight loss, ...
... give into your child,s meltdowns, expert says , SUNDAY, April ... have a hard time figuring out what to do when ... that kids often have their meltdowns in public places -- ... a Kansas State University child development expert, has compiled tips ...
... or more a week often quit their own jobs, researchers say ... more than 60 hours a week, watch out: His commitment ... , A new study finds that women with husbands who work ... expected to pick up the slack at home in regard to ...
... The law firm of Dussault ... $90,000.00 , ... 2, 2010 -- The law firm of Dussault and Zatir settled out of court a claim ... 92-year-old woman, while walking in her yard, was knocked to the ground by a neighbor’s dog. ...
... ... ... Passover and Easter, a New Jersey physician ventured into the bush country of Haiti. , ... N.J. resident, left at 4 a.m. on Friday, April 2, for a week-long medical mission ...
... tie-in to tremors and other motor problems , ... how a mutation in a gene called LRRK2 may ... , In experiments using genetically engineered mice, the Mount ... dopamine transmission and controls motor performance. Dopamine is a ...
Cached Medicine News:Health News:Belief that intentional weight loss is harmful to seniors is unfounded 2Health News:Belief that intentional weight loss is harmful to seniors is unfounded 3Health News:Dealing With Those All-Too-Public Tantrums 2Health News:Working Wives Still Expected to Do It All, Study Finds 2Health News:NJ Medical Director Travels To Haiti's Bush Country 2Health News:NJ Medical Director Travels To Haiti's Bush Country 3
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: